AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.

NACompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

April 8, 2019

Study Completion Date

April 8, 2019

Conditions
Acute Kidney Injury
Interventions
OTHER

Clinical Recommendations

"The clinical recommendations will regard the following:~1. Avoidance of potentially nephrotoxic medications (e.g. NSAIDs, intravascular contrast, nephrotoxic antimicrobials)~2. Optimizing volume status (avoidance of volume overload or depletion)~3. Optimizing electrolytes and acid-base status~4. Optimizing hemodynamics (Mean arterial BP\>65mmHg)~5. Assessment of kidney function with serum creatinine and/or cystatin C~None of the suggestions will be experimental. All suggestions will be based on standard nephrology practice."

Trial Locations (3)

32224

Mayo Clinic in Florida, Jacksonville

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER